AAP reaffirms support for routine pediatric influenza vaccination, eliminating nonmedical school vaccination exemptions and reaffirming the childhood recommended immunization schedule as published online by CDC in November 2024
In the July issue of Pediatrics, the American Academy of Pediatrics (AAP) published two policy statements. One reaffirms their ongoing support for routine pediatric influenza vaccination. The other updates and reaffirms AAP’s support since 2016 for elimination of nonmedical school vaccination exemptions. Excerpts appear below.
Recommendations for Prevention and Control of Influenza in Children, 2025–2026: Policy Statement
The AAP recommends annual influenza vaccination of all children without medical contraindications starting at 6 months of age. Influenza vaccination is an important strategy for protecting children and the broader community as well as reducing the overall burden of respiratory illnesses when other viruses are cocirculating. Any licensed influenza vaccine appropriate for age and health status can be administered, as soon as possible in the season, without preference for one product or formulation.
Medical vs Nonmedical Immunization Exemptions for Child Care and School Attendance: Policy Statement
Routine childhood immunizations against infectious diseases are an integral part of our public health infrastructure. They provide direct protection to the immunized individual and indirect protection to children and adults unable to be immunized by reducing spread of vaccine-preventable diseases in the community. . . . The American Academy of Pediatrics (AAP) supports certification of immunization to attend child care and school as a sound means of providing a safe environment for attendees and employees of these settings. The AAP also supports medically indicated exemptions to specific immunizations as determined for each individual child. The AAP advocates for the elimination of nonmedical exemptions from immunizations as contrary to optimal individual and public health.
AAP continues its support for the recommended immunization schedule for children as published by CDC online in November 2024, including routine vaccination of children against COVID-19. AAP does not endorse the CDC schedule currently online on the CDC website that does not recommend routine childhood COVID-19 vaccination. The schedule endorsed by AAP is the version that Immunize.org offered for sale as a laminated booklet until it sold out earlier this year.
Related Links
Back to top
FDA approves updated rabies vaccine package insert to include a 2-dose pre-exposure prophylaxis regimen, as recommended by ACIP and CDC in 2022
On July 24, 2025, FDA revised the rabies vaccine (Imovax Rabies, Sanofi Pasteur) package insert to include the 2-dose pre-exposure prophylaxis (PrEP) regimen. This aligns the package insert with the ACIP rabies PrEP recommendations published in MMWR on May 6, 2022. Current PrEP recommendations are for a 2-dose (days 0 and 7) intramuscular rabies vaccination series. Booster dose and titer recommendations following the 2-dose PrEP series vary by a person’s risk category.
Related Links
Children’s Hospital of Philadelphia publishes “Hepatitis B ‘Fast Facts’ for Healthcare Providers” and shares new "Vaccines Make Memories" resources
The Children’s Hospital of Philadelphia (CHOP) Vaccine Education Center (VEC) published News & Views—Hepatitis B: 'Fast Facts' for Healthcare Providers in their Vaccine Update Newsletter. This article reviews the hepatitis B virus, its transmission, the disease it causes, and why HepB vaccination continues to be critical, especially at birth.
VEC also released two new posters with the vaccine-positive message: “Vaccines Make Memories.” Available in English and Spanish, the posters focus on protecting the moments that matter most through vaccination.

The posters are available for purchase in individual quantities or in sets of 10.
Related Link
Back to top
It’s National Immunization Awareness Month! Use these resources to encourage vaccination.
August is National Immunization Awareness Month (NIAM). This annual observance highlights the importance of protecting people of all ages against vaccine-preventable diseases through on-time vaccination. This year, NIAM serves as a focal point to share trustworthy, credible information about the importance of staying up to date with routine immunizations.
Multiple partners offer resources, including social media messaging that you can use in your NIAM communication.
- Voices for Vaccines' (VFV) NIAM 2025 web page includes key messages and sample social media content, organized by week, to focus positive public attention on immunizations. This week, use VFV's resources to highlight how well vaccines work, using the hashtag #NIAM2025.
- Immunize Canada and Vaccine Ambassadors partnered on an NIAM campaign, which includes images, posters, and social media content
- Vaccinate Your Family's #FirstDayVax campaign reminds families that vaccines should be part of every back-to-school checklist. Find the shareable assets in the #FirstDayVax toolkit, also available in Spanish.

During NIAM, encourage your patients to schedule appointments to get up to date on annual exams and recommended vaccines. Research shows that healthcare providers remain the most trusted source of vaccine information for parents and patients.
Confirmed U.S. measles cases in 2025 increase to 1,333 across 39 states; Canada’s measles case count surges to 4,206 as of July 28
As of July 23, CDC reported 1,333 confirmed measles cases in 2025 in 39 states. Two-thirds of reported confirmed cases are younger than age 20 years. Just 4% of confirmed cases have occurred in people who received two doses of measles-containing vaccine.
CDC only requires reporting of laboratory-confirmed measles cases. Cases without laboratory testing for confirmation are not included in these numbers. Actual numbers of cases are, therefore, higher than confirmed case counts.
Like the United States, Canada is also experiencing a huge measles outbreak, with 4,206 confirmed and probable cases reported through July 28. During week 29 (July 13–19), 230 new cases were reported.
A map of cases in Canada is provided below:

Immunize.org offers measles-related resources for the public on several of our affiliated websites:
The Children’s Hospital of Philadelphia (CHOP) Vaccine Education Center (VEC) has produced an MMR infographic for families (below).

Related Links
“What Are the Pneumococcal Vaccination Options for a Previously Unvaccinated 50-Year-Old?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube.
This week, our featured episode from the Ask the Experts Video Series addresses the question: "What Are the Pneumococcal Vaccination Options for a Previously Unvaccinated 50-Year-Old?" The video summarizes the two new options available for adults 50 years and older with no prior pneumococcal vaccination or whose previous vaccination history is unknown.
The 1-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Website and Clinical Resources
Spotlight on the website: View our Immunize.org website on your mobile device!

The Immunize.org website adapts seamlessly to the smaller screens of tablets and smartphones with configurations that make it simple to read and use. Navigation is responsive and features easy-access links for finger scrolling.
When you open the site on a mobile device, start your search using the “hamburger” icon (three horizontal lines) or search feature at the top right of the screen. From that menu, you will see content categories. Immunize.org provides valuable content, no matter how you view us.

The Orientation Video Series, narrated by Immunize.org’s Kelly L. Moore, MD, MPH, specifically formatted for mobile devices, showcases resources offered on Immunize.org in short videos:
Recap: CDC releases at-a-glance resources for RSV products to help you prepare for respiratory virus season
CDC released four new at-a-glance resources for healthcare professionals on RSV prevention products. Each 2-page document addresses a single product. Use these resources to help your clinical team prepare for RSV prevention in adults and infants this fall. These materials are available on the CDC’s main Respiratory Syncytial Virus (RSV) Immunizations main page and include the following documents:

Related Links
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines, so vaccine outreach is more important than ever.
Materials on this colorful website for healthcare professionals incorporate the 2020 ACIP meningococcal vaccine recommendations and coverage statistics from CDC’s National Immunization Survey–Teen (NIS–Teen). One particularly popular resource on the site is the Algorithm for MenACWY Immunization in Adolescents 11 Through 18 Years of Age.
The website is divided into five easy-to-access sections:
The site also categorizes materials according to whether they are primarily of interest to providers, to adolescents, or to parents.
Visit Give2MenACWY.org and enjoy browsing (and deploying) its bountiful resources.
Related Links
"Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020–2024" published in JAMA Health Forum
In its July 25 issue, JAMA Health Forum published Global Estimates of Lives and Life-Years Saved by COVID-19 Vaccination During 2020–2024. The findings and meaning sections appear below.
Findings: This comparative effectiveness study found that COVID-19 vaccinations averted 2.5 million deaths during 2020–2024 (sensitivity range estimates, 1.4–4.0 million) and saved 15 million life-years (sensitivity range estimates, 7–24 million life-years). The estimated benefits had a steep age gradient.
Meaning: COVID-19 vaccinations had a substantial benefit on global mortality during 2020–2024, but this benefit was mostly limited to a minority of the population of older individuals.
“Influenza-Associated Acute Necrotizing Encephalopathy in U.S. Children” published in JAMA
In its July 30 issue, JAMA published Influenza-Associated Acute Necrotizing Encephalopathy in U.S. Children. This article highlights a rare, serious form of influenza infection in children, most of whom had no known health problems. The related commentary highlights the need for better surveillance and understanding of this grave non-respiratory form of influenza infection. The findings and meaning sections of the article appear below.
Findings: In this multicenter case series of 41 children from 23 U.S. hospitals, influenza-associated ANE [acute necrotizing encephalopathy] carried a 27% mortality rate despite multimodal therapy. Most patients (76%) had no significant medical history, despite 15 of 32 tested (47%) having genetic risk alleles potentially related to risk of ANE identified during diagnostic evaluation. The H1 2009 influenza A strain predominated (34% of cases), and only 16% had received seasonal influenza vaccination. Among survivors, 63% had moderate to severe disability at 90-day follow-up.
Meaning: Influenza-associated ANE represents a rare but devastating neurologic complication primarily affecting previously healthy children. The high morbidity and mortality emphasize the need for prevention, early recognition, intensive treatment, and standardized management protocols.
Related Link
Today, virtual: Register for Immunize.org Website Office Hours. Ask questions and learn about the “Official Guidance” (state resources) web section on Immunize.org on August 6 at 4:00 p.m. (ET) or August 7 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, August 6 at 4:00 p.m. (ET) or Thursday, August 7 at 12:00 p.m. (ET). The same content will be covered in both sessions.
We will open each 45-minute session with a short, live demonstration on navigating the Official Guidance ("State Policies" and related resources) website section on Immunize.org. This section was updated in July with 2025 data on state vaccination requirements for school and childcare. You can submit questions when you register or live on Zoom during the session.

Register today for Immunize.org Website Office Hours (content is the same for both):
The archive of previous Website Office Hours content is posted at Immunize.org’s "Webinars & Videos" page. These archived programs include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Affiliated Websites; Images, Webinars, Videos, & Social Media; Let's Get Real About Vaccines Website; News & Updates; Official Guidance Part 1 & 2; Publication Archives, Vaccine Timeline, & About Us; Travel Vaccines, Vaccine Confidence, & Addressing Concerns; and Vaccines A–Z.
Mark your calendar for future Immunize.org Website Office Hours.
Virtual: Children’s Hospital of Philadelphia hosts Current Issues in Vaccines webinar titled “Aluminum Adjuvants: Separating Fact from Fear” on September 10 at 12:00 p.m. (ET); CE credit offered
The Vaccine Education Center (VEC) at Children's Hospital of Philadelphia (CHOP) will present a 1-hour webinar titled Aluminum Adjuvants: Separating Fact from Fear beginning at 12:00 p.m. (ET) on September 10. Part of its Current Issues in Vaccines series, the webinar will feature Paul Offit, MD, director of the VEC.
Free continuing education credits (CME, CEU, and CPE) will be available for both the live and archived events.
Register for the webinar.
|